Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy is a research paper published in RMD Open (2022). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K23 AR073334
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30 AR070253
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30 AR072577
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01 AR077607
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R03 AR078938
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: T32 AR007258
National Institutes of Health
Grant: 5P30AR072577-05
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
National Institutes of Health
Grant: 5R01AR077607-02
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease
National Institutes of Health
Grant: 5R03AR078938-02
Personalizing AAV Management by Leveraging Big Data: Targeting Complication Clusters
National Institutes of Health
Grant: 5P30AR070253-04
Joint Biology Consortium Resource-based Center
National Institutes of Health
Grant: 5K23AR073334-03
Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated Vasculitis
National Institutes of Health
Grant: 2T32AR007258-46
Research Training in Rheumatology at Massachusetts General Hospital
FWCI
1.06
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals